CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,993 | $235.35 | $1.2M | 479,803 |
| 2026-10-23 | Rider Michael J Global General Counsel | Sale 10b5-1 | −400 | $255.00 | $102K | 12,318 |
| 2026-10-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $226.33 | $1.1M | 479,803 |
| 2026-09-08 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $222.44 | $1.1M | 466,256 |
| 2026-09-02 | FARRELL PETER C Director | Sale 10b5-1 | −970 | $234.73 | $228K | 51,803 |
| 2026-08-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $205.69 | $1.0M | 466,256 |
| 2026-08-05 | FARRELL PETER C Director | Sale 10b5-1 | −8,000 | $225.00 | $1.8M | 52,773 |
| 2026-07-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $218.55 | $1.1M | 466,223 |
| 2026-06-08 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $193.96 | $968K | 466,256 |
| 2026-05-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $207.82 | $1.0M | 466,223 |
| 2026-04-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $225.50 | $1.1M | 466,223 |
| 2026-04-01 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $224.31 | $224K | 83,495 |
| 2026-04-01 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $225.00 | $450K | 60,773 |
| 2026-03-09 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $251.03 | $1.3M | 466,223 |
| 2026-03-04 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $260.22 | $520K | 62,773 |
| 2026-03-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $254.30 | $254K | 84,495 |
| 2026-02-09 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $273.78 | $1.4M | 466,223 |
| 2026-02-04 | FARRELL PETER C Director | Sale 10b5-1 | −2,000 | $251.31 | $503K | 64,773 |
| 2026-02-04 | Rider Michael J Global General Counsel | Sale 10b5-1 | −50 | $260.00 | $13K | 9,691 |
| 2026-02-02 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $257.03 | $257K | 85,495 |
Page 1 of 6 · 117 trades